| DICOM PS3.3 2016a - Information Object Definitions |
|---|
Table C.8.22-9 contains IOD Attributes that describe a PET Isotope.
Table C.8.22-9. Enhanced PET Isotope Module Attributes
|
Identifying number, unique within this SOP Instance, of the agent administered. Used to reference this particular agent from the Radiopharmaceutical Functional Group Macro. The number shall be 1 for the first item and increase by 1 for each subsequent Item. |
|||
|
Baseline CID 4020 “PET Radionuclide”. |
|||
|
Sequence that identifies the administration route of the radiopharmaceutical. |
|||
|
Baseline CID 11 “Route of Administration”. |
|||
|
Time of start of administration. The actual time of radiopharmaceutical administration to the patient for imaging purposes. |
|||
|
Time of end of administration. The actual ending time of radiopharmaceutical administration to the patient for imaging purposes. |
|||
|
The radiopharmaceutical dose administered to the patient measured in MegaBecquerels (MBq) at the Radiopharmaceutical Start DateTime (0018,1078). |
|||
|
Unique identification of the administration of the radiopharmaceutical to the patient. |
|||
|
The radionuclide half life, in seconds, that was used in the correction of this image. |
|||
|
The radionuclide positron fraction (fraction of decays that are by positron emission) that was used in the correction of this image. |
|||
|
The activity per unit mass of the radiopharmaceutical, in Bq/micromole, at the Radiopharmaceutical Start DateTime (0018,1078). |
|||
|
Baseline CID 4021 “PET Radiopharmaceutical”. |
|||
| DICOM PS3.3 2016a - Information Object Definitions |
|---|